IP Library › Granted Patent US 12,391,834
Granted Patent B2
US 12,391,834 · App. 18/423,259 · Granted Aug 19, 2025

Protected dye-labeled reagents

Inventors: Lubomir Sebo (Redwood City, CA); Honey Osuna (San Francisco, CA); Stephen Yue (Eugene, OR); Yuri Lapin (Newark, CA)
Assignee: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
C09B69/105C07D495/04C07H19/10C07H19/207C12Q1/6869G01N21/6428G01N2021/6439
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,391,834
App. No.
18/423,259
Granted
Aug 19, 2025
Kind
B2
Abstract

Labeled nucleotide analogs comprising at least one avidin protein, at least one dye-labeled compound, and at least one nucleotide compound are provided. The analogs are useful in various fluorescence-based analytical methods, including the analysis of highly multiplexed optical reactions in large numbers at high densities, such as single molecule real time nucleic acid sequencing reactions. The analogs are detectable with high sensitivity at desirable wavelengths. They contain structural components that modulate the interactions of the analogs with DNA polymerase, thus decreasing photodamage and improving the kinetic and other properties of the analogs in sequencing reactions. Also provided are nucleotide and dye-labeled compounds of the subject analogs, as well as intermediates useful in the preparation of the compounds and analogs. Compositions comprising the compounds, methods of synthesis of the intermediates, compounds, and analogs, and mutant DNA polymerases are also provided.

Claims (43)

1. A dye-labeled compound of structural formula (IIIA), (IIIB), (IIIC), (IIID), or (IIIE):

wherein

each L′ is independently a dye compound linker element;

each S is independently a shield element;

each A is independently an acceptor dye;

each D is independently a donor dye;

each B″ is independently a terminal coupling element;

each p is independently 0 or 1; and

each r is independently an integer from 0 to 8;

wherein the compound comprises at least one shield element, at least one acceptor dye, and at least one donor dye; and

wherein the compound does not contain a nucleoside.

2. The dye-labeled compound of claim 1 , wherein each r is independently an integer from 0 to 4.

3. The dye-labeled compound of claim 1 comprising at least two donor dyes.

4. The dye-labeled compound of claim 3 comprising at least four donor dyes.

5. The dye-labeled compound of claim 1 comprising at least two acceptor dyes.

6. The dye-labeled compound of claim 5 comprising at least four acceptor dyes.

7. The dye-labeled compound of claim 1 comprising at least two donor dyes and at least two acceptor dyes.

8. The dye-labeled compound of claim 1 , wherein at least one dye compound linker element comprises a shield element or a side chain element.

9. The dye-labeled compound of claim 1 , wherein the at least one shield element comprises a plurality of side chains.

10. The dye-labeled compound of claim 9 , wherein at least one side chain has a molecular weight of at least 300.

11. The dye-labeled compound of claim 9 , wherein all of the side chains have a molecular weight of at least 300.

12. The dye-labeled compound of claim 9 , wherein at least one side chain comprises a polyethylene glycol.

13. The dye-labeled compound of claim 9 , wherein at least one side chain comprises a negatively-charged component.

14. The dye-labeled compound of claim 13 , wherein the negatively-charged component comprises a sulfonic acid.

15. The dye-labeled compound of claim 9 , wherein at least one side chain comprises a substituted phenyl group.

16. The dye-labeled compound of claim 15 , wherein the at least one side chain comprises the structure:

wherein each x is independently an integer from 1 to 6.

17. The dye-labeled compound of claim 16 , wherein each x is independently an integer from 1 to 4.

18. The dye-labeled compound of claim 9 , wherein at least one side chain comprises a triazole.

19. The dye-labeled compound of claim 9 , wherein at least one side chain comprises the structure:

20. The dye-labeled compound of claim 1 , wherein the at least one shield element comprises the structure:

wherein each y is independently an integer from 1 to 6.

21. The dye-labeled compound of claim 1 , wherein the at least one shield element comprises the structure:

22. The dye-labeled compound of claim 1 comprising two terminal coupling elements.

23. The dye-labeled compound of claim 1 , wherein the terminal coupling element comprises a biotin moiety.

24. The dye-labeled compound of claim 23 , wherein the terminal coupling element comprises a bis-biotin moiety.

25. The dye-labeled compound of claim 1 , wherein the at least one acceptor dye or the at least one donor dye is a cyanine dye.

26. A labeled reagent composition comprising an avidin protein and the dye-labeled compound of claim 1 .

27. The dye-labeled compound of claim 1 , wherein the terminal coupling element comprises a first reactive functional group.

28. The dye-labeled compound of claim 1 , wherein the terminal coupling element comprises a residue derived from a first reactive functional group.

29. The dye-labeled compound of claim 28 , wherein the residue derived from the first reactive functional group is an amide moiety.

30. The dye-labeled compound of claim 28 , wherein the residue derived from the first reactive functional group results from a click reaction.

31. The dye-labeled compound of claim 1 , wherein the terminal coupling element is connected by the residue derived from the first reactive functional group to a nucleotide compound.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2024
From: SEBO, LUBOMIR; OSUNA, HONEY; YUE, STEPHEN; LAPIN, YURI
To: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Reel/Frame 066862/0159 →
Continuity (5)
Continuation 17556800 · Dec 20, 2021
Continuation 16779439 · Jan 31, 2020
Continuation 15357965 · Nov 21, 2016
Provisional Application 62258415 · Nov 20, 2015
Related Publication 20240158640A1 · May 16, 2024
References Cited (100)
US 4711955A · Ward et al. · 1987 [cited by applicant]
US 5223384A · Ohbayashi et al. · 1993 [cited by applicant]
US 5688648A · Mathies et al. · 1997 [cited by applicant]
US 6153442A · Pirio et al. · 2000 [cited by applicant]
US 6255083B1 · Williams · 2001 [cited by applicant]
US 6399335B1 · Kao et al. · 2002 [cited by applicant]
US 6787308B2 · Balasubramanian et al. · 2004 [cited by applicant]
US 6917726B2 · Levene et al. · 2005 [cited by applicant]
US 7013054B2 · Levene et al. · 2006 [cited by applicant]
US 7041812B2 · Kumar et al. · 2006 [cited by applicant]
US 7056661B2 · Korlach et al. · 2006 [cited by applicant]
US 7405281B2 · Xu et al. · 2008 [cited by applicant]
US 7476503B2 · Turner et al. · 2009 [cited by applicant]
US 7767805B2 · Buzby · 2010 [cited by applicant]
US 7777013B2 · Xu et al. · 2010 [cited by applicant]
US 7842475B2 · Zheng et al. · 2010 [cited by applicant]
US 7906284B2 · Turner et al. · 2011 [cited by applicant]
US 7968702B2 · Wegener et al. · 2011 [cited by applicant]
US 7973146B2 · Shen et al. · 2011 [cited by applicant]
US 8058031B2 · Xu et al. · 2011 [cited by applicant]
US 8133672B2 · Bjornson et al. · 2012 [cited by applicant]
US 8133702B2 · Shen et al. · 2012 [cited by applicant]
US 8182993B2 · Tomaney et al. · 2012 [cited by applicant]
US 8236499B2 · Patel et al. · 2012 [cited by applicant]
US 8257954B2 · Clark et al. · 2012 [cited by applicant]
US 9062091B2 · Bjornson et al. · 2015 [cited by applicant]
US 10669299B2 · Sebo · 2020 [cited by examiner]
US 11203689B2 · Sebo · 2021 [cited by examiner]
US 11884826B2 · Sebo · 2024 [cited by examiner]
US 20030077610A1 · Nelson et al. · 2003 [cited by applicant]
US 20030162213A1 · Fuller et al. · 2003 [cited by applicant]
US 20030162216A1 · Gold et al. · 2003 [cited by applicant]
US 20040241716A1 · Kumar et al. · 2004 [cited by applicant]
US 20060281911A1 · Beaucage et al. · 2006 [cited by applicant]
US 20070249652A1 · Parenty et al. · 2007 [cited by applicant]
US 20080076189A1 · Belosludtsev et al. · 2008 [cited by applicant]
US 20090024331A1 · Tomaney et al. · 2009 [cited by applicant]
US 20090118129A1 · Turner · 2009 [cited by applicant]
US 20090142316A1 · Majoral et al. · 2009 [cited by applicant]
US 20090186343A1 · Wang et al. · 2009 [cited by applicant]
US 20090208957A1 · Korlach et al. · 2009 [cited by applicant]
US 20090325260A1 · Otto et al. · 2009 [cited by applicant]
US 20100075328A1 · Bjornson et al. · 2010 [cited by applicant]
US 20100136592A1 · Kong et al. · 2010 [cited by applicant]
US 20100152424A1 · Korlach et al. · 2010 [cited by applicant]
US 20100167299A1 · Korlach · 2010 [cited by applicant]
US 20100221716A1 · Flusberg et al. · 2010 [cited by applicant]
US 20100255488A1 · Kong et al. · 2010 [cited by applicant]
US 20100261185A1 · Nikiforov · 2010 [cited by applicant]
US 20110183320A1 · Flusberg et al. · 2011 [cited by applicant]
US 20110244447A1 · Korlach · 2011 [cited by applicant]
US 20110256618A1 · Eid et al. · 2011 [cited by applicant]
US 20120052506A1 · Yue et al. · 2012 [cited by applicant]
US 20120052507A1 · Shen · 2012 [cited by applicant]
US 20120058469A1 · Shen · 2012 [cited by applicant]
US 20120058473A1 · Yue et al. · 2012 [cited by applicant]
US 20120058482A1 · Shen et al. · 2012 [cited by applicant]
US 20120077189A1 · Shen et al. · 2012 [cited by applicant]
US 20120115736A1 · Bjornson et al. · 2012 [cited by applicant]
US 20120122779A1 · Kirshenbaum et al. · 2012 [cited by applicant]
US 20130289253A1 · Luescher et al. · 2013 [cited by applicant]
US 20130316912A1 · Bjornson · 2013 [cited by examiner]
US 20140005404A1 · Yue et al. · 2014 [cited by applicant]
US 20140080127A1 · Yue et al. · 2014 [cited by applicant]
US 20140094374A1 · Kamtekar et al. · 2014 [cited by applicant]
US 20140094375A1 · Kamtekar et al. · 2014 [cited by applicant]
US 20150050659A1 · Sebo et al. · 2015 [cited by applicant]
US 20160237279A1 · Zheng et al. · 2016 [cited by applicant]
US 20170145495A1 · Sebo et al. · 2017 [cited by applicant]
US 20170184580A1 · Shen et al. · 2017 [cited by applicant]
WO 1991006678A1 · 1991 [cited by applicant]
WO 1996027025A1 · 1996 [cited by applicant]
WO 2009145828A2 · 2009 [cited by applicant]
WO 2010057185A1 · 2010 [cited by applicant]
WO 2012027618A2 · 2012 [cited by applicant]
WO 2012027625A2 · 2012 [cited by applicant]
WO 2013123258A1 · 2013 [cited by applicant]
WO 2013173844A1 · 2013 [cited by applicant]
WO 2017087973A1 · 2017 [cited by applicant]
WO 2017087974A1 · 2017 [cited by applicant]
WO 2017087975A1 · 2017 [cited by applicant]
Astruc et al. (2010) Chem. Rev. 110:1857-1959. [cited by applicant]
Baskin et al. (2007) PNAS 104:16793-16797. [cited by applicant]
Brief Communication re cancellation of oral proceedings Dated Mar. 1, 2022 for Related EP16867351.5. [cited by applicant]
Brief Communication re oral proceedings Dated Feb. 28, 2022 for Related EP16867351.5. [cited by applicant]
Eid et al. (2009) Science 323:133-158. [cited by applicant]
Evans (2007) Aus. J. Chem. 60:384-395. [cited by applicant]
Extended European Search Report Dated Jun. 25, 2019 for Related EP16867351.5. [cited by applicant]
Extended European Search Report Dated Jun. 29, 2023 for Related EP22192143.0. [cited by applicant]
Genisphere Poc Tech. Note (2012). [cited by applicant]
Intention to grant Dated Mar. 22, 2022 for Related EP16867351.5. [cited by applicant]
International Search Report and Written Opinion Dated Apr. 4, 2017 for Related PCT/US2016/063177. [cited by applicant]
Kim et al. (2013) Biophys. J. 104:1566-1575. [cited by applicant]
Kolb et al. (2001) Angew. Chem. Int. Ed. Engl. 40:2004-20212. [cited by applicant]
Levene et al. (2003) Science 299:682-686. [cited by applicant]
Office Communication Dated Aug. 3, 2020 for Related EP16867351.5. [cited by applicant]
PubChem CID 11341015. [cited by applicant]
PubChem CID 3514056. [cited by applicant]
Siriporn et al. (2009) ChemComm pp. 806-808. [cited by applicant]
Summons to attend oral proceedings Dated Oct. 5, 2021 for Related EP16867351.5. [cited by applicant]